QPS ups capacity to support large-scale Ph III trials
QPS Holdings, LLC is investing in personnel and laboratory capacity for translational medicine at its headquarters in Delaware Technology Park.
Archives for August 7, 2017
Valeant’s site for sore eyes: US FDA again issues CRL
The US FDA has rejected Valeant Pharmaceuticals International’s eye drop candidate following a site inspection at its subsidiary’s facility in Tampa, Florida, US.
Japan tells Pfizer, Bayer, Daichi and others to expand drug warnings
The MHLW has ordered Pfizer, Bayer, Daichi Sankyo and firms selling generic warfarin and azithromycin in Japan to expand their products’ adverse event warnings.
Keeping pace? Medpace anticipates growth, continues investment
Medpace stresses a continued investment in human resources as it anticipates growth and further opportunities from the small- and mid-sized biopharma market.
Progressing patient-derived material a 'key strategic focus,' says Evotec CEO
Evotec and Fraunhofer IME-SP have signed a strategic collaboration to advance Evotec’s patient-derived iPSC platform and subsequent drug discovery projects.
update
Hep B vaccine supply issues at Merck & Co and GSK prompt UK to prioritize access
Public Health England has reserved NHS hepatitis B vaccine stocks for people at high risk of infection, citing shortages caused by production interruptions at Merck & Co and GSK.